Latest Options News

US Masters Residential Property Group has surpassed its 2025 sales target with over US$200 million in property sales and significantly reduced its debt, while maintaining steady distributions to investors.

St Barbara Limited reports solid progress on its Simberi Expansion Project and Atlantic 15-Mile Processing Hub, with key milestones reached and strategic options under review.

Buru Energy has issued 52.5 million attaching options to shareholders involved in its recent placement, following shareholder approval at the November 18 General Meeting.

State Gas Limited has independently certified a maiden 2P gas reserve of 30.2 petajoules at its Rolleston West Project, establishing a solid foundation for a pipeline-connected gas development aimed at the east coast market.

Horizon Gold Limited has reaffirmed the strength of its Gum Creek Gold Project, boasting a 2.3 million ounce resource and progressing steadily towards a feasibility study completion in early 2026. The project’s strategic location and existing infrastructure underpin a rapid restart potential.

Emyria Limited is fast-tracking its national rollout of Empax mental health clinics, backed by a strong $8 million institutional placement and new dual-payer funding pathways.

Amplia Therapeutics has secured positive feedback from the US FDA on its Phase 2b/3 trial design for narmafotinib in pancreatic cancer, paving the way for a late 2026 trial start.

Dalrymple Bay Infrastructure Limited has reaffirmed its position as the world’s largest metallurgical coal export facility with full contracted capacity through 2028 and unveiled detailed plans for a significant terminal expansion.

ReNerve Limited has raised $3.2 million through a two-tranche share placement to accelerate its sales and marketing efforts in the US and support upcoming product launches, including a new nerve conduit range.

Cazaly Resources has raised $3.5 million through a strongly supported placement to accelerate reverse circulation drilling at its Goongarrie Gold Project in Western Australia. The capital injection positions the company to expand exploration efforts and advance key targets in a promising gold region.

DroneShield Limited has clarified the recent exercise and sale of shares by its directors following performance option vesting, alongside addressing an erroneous contract announcement that was later withdrawn. The company also outlined steps to enhance compliance with ASX continuous disclosure and trading policies.

Apiam Animal Health reported a challenging FY25 with underperformance in its core clinical segment but has rebounded strongly in Q1 FY26. The company is now poised for acquisition by Adamantem Capital, offering shareholders a premium cash and scrip deal.